KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
-10.97%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$388M
AUM Growth
+$388M
(+26%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
30.85%
Top 10 Holdings %
Top 10 Hldgs %
79.4%
Holding
38
New
3
Increased
17
Reduced
11
Closed
3
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$27.5M |
| 2 |
Vera Therapeutics
VERA
|
$13.9M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$11.1M |
| 4 |
BNR
Burning Rock Biotech
BNR
|
$10.3M |
| 5 |
Celldex Therapeutics
CLDX
|
$10.2M |
Top Sells
| 1 |
Xenon Pharmaceuticals
XENE
|
$9.38M |
| 2 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$6.2M |
| 3 |
RDUS
Radius Health, Inc.
RDUS
|
$1.64M |
| 4 |
Krystal Biotech
KRYS
|
$1.22M |
| 5 |
Wave Life Sciences
WVE
|
$699K |
Sector Composition
| 1 | Healthcare | 98.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $70.3M | 17.95% | 2,200,000 +860,678 | +64% | +$27.5M |
|
|
2
Syndax Pharmaceuticals
SNDX
$1.41B
| $48.3M | 12.34% | 2,512,240 +579,440 | +30% | +$11.1M |
|
3
Natera
NTRA
$23.1B
| $43.9M | 11.21% | 1,239,047 +272,647 | +28% | +$9.66M |
|
|
4
Celldex Therapeutics
CLDX
$1.47B
| $30.5M | 7.8% | 1,132,259 +379,225 | +50% | +$10.2M |
|
5
Travere Therapeutics
TVTX
$1.56B
| $29.9M | 7.64% | 1,235,151 +364,233 | +42% | +$8.83M |
|
|
6
Vera Therapeutics
VERA
$1.38B
| $20.7M | 5.29% | 1,522,712 +1,020,384 | +203% | +$13.9M |
|
7
Gossamer Bio
GOSS
$562M
| $19.7M | 5.02% | 2,350,448 +517,744 | +28% | +$4.33M |
|
8
Biogen
BIIB
$19.4B
| $16.1M | 4.11% | 78,951 +40,715 | +106% | +$8.3M |
|
9
Vaxcyte
PCVX
$4B
| $15.7M | 4.02% | 723,781 +144,141 | +25% | +$3.14M |
|
|
BNR
10
Burning Rock Biotech
BNR
$93.6M
| $12.5M | 3.2% | 4,300,000 +3,526,886 | +456% | +$10.3M |
|
11
BioCryst Pharmaceuticals
BCRX
$1.74B
| $9.91M | 2.53% | +936,563 | New | +$9.91M |
|
12
Amicus Therapeutics
FOLD
$2.34B
| $9.67M | 2.47% | 900,000 +326,484 | +57% | +$3.51M |
|
13
Cogent Biosciences
COGT
$1.69B
| $9.02M | 2.3% | +1,000,000 | New | +$9.02M |
|
14
Viridian Therapeutics
VRDN
$1.5B
| $6.83M | 1.74% | 590,143 +317 | +0.1% | +$3.67K |
|
15
Liquidia Corp
LQDA
$2.38B
| $6.54M | 1.67% | 1,500,718 +341,044 | +29% | +$1.49M |
|
|
AMRN
16
Amarin Corp
AMRN
$311M
| $5.98M | 1.53% | 4,009,893 +1,715,811 | +75% | +$2.56M |
|
|
17
Wave Life Sciences
WVE
$1.53B
| $5.51M | 1.41% | 1,696,735 -214,993 | -11% | -$699K |
|
|
18
Xenon Pharmaceuticals
XENE
$2.98B
| $5.32M | 1.36% | 175,000 -308,270 | -64% | -$9.38M |
|
|
CNCE
19
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.21M | 1.08% | +1,000,000 | New | +$4.21M |
|
|
CNTA
20
Centessa Pharmaceuticals
CNTA
$2.25B
| $3.69M | 0.94% | 757,848 +88,748 | +13% | +$432K |
|
21
Merus
MRUS
$4.98B
| $2.35M | 0.6% | 103,627 -13,137 | -11% | -$297K |
|
22
Fate Therapeutics
FATE
$120M
| $2.01M | 0.51% | 81,064 -10,273 | -11% | -$255K |
|
|
AFMD
23
DELISTED
Affimed
AFMD
| $1.94M | 0.5% | 701,029 +353,064 | +101% | +$978K |
|
|
AKUS
24
DELISTED
Akouos, Inc. Common Stock
AKUS
| $1.8M | 0.46% | 383,784 -4,108 | -1% | -$19.3K |
|
25
Puma Biotechnology
PBYI
$254M
| $1.65M | 0.42% | 579,915 -73,530 | -11% | -$210K |
|